Home
News & Events
Upcoming events
News
-
Eindrapportage deelopdrachten van het deelprogramma Regulatoire Pandemische Paraatheid gepubliceerd
Na de eerdere presentatie van de voorlopige resultaten van het ZonMw deelprogramma Regulatoire Pandemische Paraatheid op het Ministerie van VWS in november en -
Register now for the RSNN Annual Workshop 2024: Artificial intelligence in Regulatory Innovation
Registration for the RSNN Annual Workshop 2024: "Artificial Intelligence in Regulatory Innovation" is now open. The event will take place in person at Villa Jongerius in Utrecht. Please visit the event site for registration. -
Deelprogramma Regulatoire Pandemische Paraatheid: eindrapport onderzoeksthema Drug Repurposing nu beschikbaar
Na de eerdere presentatie van de voorlopige resultaten van het ZonMw deelprogramma Regulatoire Pandemische Paraatheid op het Ministerie van VWS in November en de publicatie van de -
Terugblik op de geslaagde RSNN lunch webinar "Klinisch Onderzoeksklimaat in Nederland"
Op 8 februari 2024 organiseerde het RSNN in samenwerking met Dutch Clinical Research Foundation (DCRF) en andere stakeholders een lunch webinar met meer dan 160 deelnemers. -
RSNN Expert Meeting Report: Dutch Clinical Trial Landscape
On 25 October 2023 the RSNN Expert Meeting “Dutch Clinical Trial Landscape” took place. The full report (in Dutch) of the meeting is available now: pdf link. -
RSNN Newsletter December 2023
A new edition of the RSNN Newsletter has just been published. -
RSNN interview series: Thera Max-Mos
The RSNN interview series aims to give a better insight into the persons and organizations involved in the activities of RSNN. The series also provide an opportunity to highlight some of the current topics in the Regulatory Science field. -
Eerste drie finale deelrapporten deelprogramma Regulatoire Pandemische Paraatheid nu beschikbaar
Vorige week werden de resultaten van de verschillende onderzoeksthema’s binnen het deelprogramma Regulatoire Pandemische Paraatheid gepresenteerd op het ministerie van Volksgezondheid, Welzijn en -
Resultaten deelprogramma Regulatoire Pandemische Paraatheid gepresenteerd
Vandaag zijn tijdens een bijeenkomst op het ministerie van Volksgezondheid, Welzijn en Sport (VWS) de resultaten van de verschillende onderzoeksthema’s binnen het deelprogramma Regulatoire Pandemische Paraatheid gepresenteerd. Bij de presentatie waren vertegenwoordigers van ZonMw, het Ministerie van VWS, FAST, RSNN en andere betrokkenen aanwezig. -
RSNN Expert Meeting Report: New Approach Methodologies (NAMS)
On 23 May 2023, the Regulatory Science Network Netherlands (RSNN) organized an expert meeting on the topic of: 'Facilitating human relevant safety assessment of medicinal products: towards implementation of new approach methodologies (NAMs)’. -
RSNN Expert Meeting Report - Direct Healthcare Professional Communication: Recommendations to improve impact
On 4 April 2023, the Regulatory Science Network Netherlands (RSNN) organized an expert meeting on the topic of ‘Direct Healthcare Professional Communication: Recommendations to improve impact’. The full report of the Expert Meeting is available now. -
Meet us at the FIGON Dutch Medicines Days
During the upcoming FIGON Dutch Medicines days on 20 and 21 September, the RSNN will organize a session about pandemic preparedness in the context of regulation. -
2023 RSNN Annual Workshop Report available now
The full report of the RSNN Annual Workshop titled "Pharmaceutical regulation - Highway to innovation”." which took place on 6 June 2023 is now available. -
RSNN SIG Advanced Therapies workshop and networking event: presentation file and photos now available
On 6 June the RSNN Special Interest Group Advanced Therapies organized its workshop and networking event. We are looking back at a successful morning with great interaction. -
RSNN workshop 2023: presentation files and photos now available
On 6 June the RSNN organized its Annual Workshop. We are looking back at a successful afternoon with great interaction, inspiring speakers and insights from various stakeholder groups (patients, industry, academia, and regulators) on the topic of "pharmaceutical regulation - highway to innovation".